Omeq Medical signs $3 million agreement with Pharos Medical for China market

Omeq Medical Ltd. signed a $3 million investment and commercialization agreement with Pharos Medical for its smart epidural device in China. Pharos will establish a production line in China and support global efforts, with CFDA clearance and production expected by mid-2020.

“Omeq Medical Ltd. announced today that it has signed an investment and commercialization agreement for its smart epidural device with Pharos Medical.”prnewswire.com

• 1 source
• prnewswire.comOmeq Medical Penetrates Epidural Market in China Through US$3 Million Funding and Commercialization Agreement With Pharos MedicalOmeq MedicalJan 29, 2019

Summarized from public sources; check the original articles before acting on it.